Eberle AN - Search Results

1

Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake.

Froidevaux S, Calame-Christe M, Tanner H, Eberle AN. Froidevaux S, et al. Among authors: eberle an. J Nucl Med. 2005 May;46(5):887-95. J Nucl Med. 2005. PMID: 15872364 Free article.

2

Somatostatin analogs and radiopeptides in cancer therapy.

Froidevaux S, Eberle AN. Froidevaux S, et al. Among authors: eberle an. Biopolymers. 2002;66(3):161-83. doi: 10.1002/bip.10256. Biopolymers. 2002. PMID: 12385036 Review.

3

A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.

Froidevaux S, Calame-Christe M, Tanner H, Sumanovski L, Eberle AN. Froidevaux S, et al. Among authors: eberle an. J Nucl Med. 2002 Dec;43(12):1699-706. J Nucl Med. 2002. PMID: 12468522 Free article.

4

Homologous regulation of melanocortin-1 receptor (MC1R) expression in melanoma tumor cells in vivo.

Froidevaux S, Eberle AN. Froidevaux S, et al. Among authors: eberle an. J Recept Signal Transduct Res. 2002 Feb-Nov;22(1-4):111-21. doi: 10.1081/rrs-120014590. J Recept Signal Transduct Res. 2002. PMID: 12503610

5

DOTA alpha-melanocyte-stimulating hormone analogues for imaging metastatic melanoma lesions.

Froidevaux S, Calame-Christe M, Sumanovski L, Tanner H, Eberle AN. Froidevaux S, et al. Among authors: eberle an. Ann N Y Acad Sci. 2003 Jun;994:378-83. doi: 10.1111/j.1749-6632.2003.tb03203.x. Ann N Y Acad Sci. 2003. PMID: 12851339

6

Radiolabeled alpha-melanocyte-stimulating hormone analogs for receptor-mediated targeting of melanoma: from tritium to indium.

Eberle AN, Froidevaux S. Eberle AN, et al. J Mol Recognit. 2003 Sep-Oct;16(5):248-54. doi: 10.1002/jmr.633. J Mol Recognit. 2003. PMID: 14523936 Review.

7

A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.

Froidevaux S, Calame-Christe M, Schuhmacher J, Tanner H, Saffrich R, Henze M, Eberle AN. Froidevaux S, et al. Among authors: eberle an. J Nucl Med. 2004 Jan;45(1):116-23. J Nucl Med. 2004. PMID: 14734683 Free article.

8

Dimeric DOTA-alpha-melanocyte-stimulating hormone analogs: synthesis and in vivo characteristics of radiopeptides with high in vitro activity.

Bapst JP, Froidevaux S, Calame M, Tanner H, Eberle AN. Bapst JP, et al. Among authors: eberle an. J Recept Signal Transduct Res. 2007;27(5-6):383-409. doi: 10.1080/10799890701723528. J Recept Signal Transduct Res. 2007. PMID: 18097939

9

Glycosylated DOTA-alpha-melanocyte-stimulating hormone analogues for melanoma targeting: influence of the site of glycosylation on in vivo biodistribution.

Bapst JP, Calame M, Tanner H, Eberle AN. Bapst JP, et al. Among authors: eberle an. Bioconjug Chem. 2009 May 20;20(5):984-93. doi: 10.1021/bc900007u. Bioconjug Chem. 2009. PMID: 19388674

10

MSH radiopeptides for targeting melanoma metastases.

Eberle AN, Bapst JP, Calame M, Tanner H, Froidevaux S. Eberle AN, et al. Adv Exp Med Biol. 2010;681:133-42. doi: 10.1007/978-1-4419-6354-3_11. Adv Exp Med Biol. 2010. PMID: 21222266 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters